Published in Hospital Business Week, December 31st, 2006
This medication has been approved by the Food and Drug Administration (FDA) for the treatment of adult individuals with bipolar disorder and schizophrenia. In order to participate in this research study, children must:
1) Be between the ages of 6 and 17 years
2) Have a diagnosis of autistic disorder
3) Meet behavioral questionnaire guidelines
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week